OMNIPAQUE 180 mg/mL

OMNIPAQUE 180 mg/mL is a radiopaque contrast medium used for diagnostic imaging procedures. This Iohexol-based solution enhances visibility in X-rays and CT scans, aiding in accurate diagnosis. Suitable for intrathecal, oral, and rectal administration.

OMNIPAQUE 180 mg/mL is primarily used as a contrast agent to improve the clarity of images during diagnostic imaging. It is commonly employed in procedures such as computed tomography (CT) scans, angiography, and myelography. The solution helps healthcare professionals visualize structures within the body more clearly, facilitating better diagnosis and treatment planning. What is OMNIPAQUE used for? It is often utilized in imaging studies to enhance the visibility of blood vessels, spinal cord, and other internal organs.

Common effects of OMNIPAQUE 180 mg/mL may include a temporary warm sensation or a metallic taste in the mouth. Some individuals might experience mild nausea or vomiting. These effects are generally short-lived and subside quickly. Severe reactions are rare but can occur, and immediate medical attention should be sought if any unusual symptoms arise.

OMNIPAQUE 180 mg/mL should be used with caution in individuals with a history of allergic reactions to contrast media. It is important to inform healthcare providers about any existing medical conditions or allergies before administration. Proper handling and storage are essential to maintain the integrity of the solution. Always follow the guidelines provided by healthcare professionals for safe usage.

OMNIPAQUE 180 mg/mL may interact with certain medications, particularly those that affect kidney function. It is advisable to disclose all current medications to healthcare providers to avoid potential interactions. Alcohol and other substances that can affect kidney function should be avoided. Always consult with a healthcare professional for personalized advice.